(Q38294189)

1 September 2017

1 reference

title

Plasmacytoid dendritic cells, a role in neoplastic prevention and progression (English)

1 reference

1 September 2017

1 reference

1

Vincent C Lombardi

0 references

Svetlana F. Khaiboullina

series ordinal

2

object named as

Svetlana F Khaiboullina

0 references

Älbirt Rizwanof

series ordinal

3

object named as

Albert A Rizvanov

0 references

publication date

1 January 2015

1 reference

European Journal of Clinical Investigation

1 September 2017

1 reference

1 September 2017

45 Suppl 1

1 reference

1 September 2017

1-8

1 reference

The nature of the principal type 1 interferon-producing cells in human blood

1 September 2017

1 reference

Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology

21 January 2018

1 reference

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

21 January 2018

1 reference

The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway.

21 January 2018

1 reference

Human and mouse plasmacytoid dendritic cells.

21 January 2018

1 reference

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

21 January 2018

1 reference

Differential production of inflammatory chemokines by murine dendritic cell subsets

21 January 2018

1 reference

Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?

21 January 2018

1 reference

Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.

21 January 2018

1 reference

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

Cancer and the chemokine network

21 January 2018

1 reference

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

A critical role for macrophages in promotion of urethane-induced lung carcinogenesis

21 January 2018

1 reference

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer

21 January 2018

1 reference

ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.

21 January 2018

1 reference

Steady-state and inflammatory dendritic-cell development

21 January 2018

1 reference

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

21 January 2018

1 reference

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod

21 January 2018

1 reference

Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells

21 January 2018

1 reference

Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.

21 January 2018

1 reference

Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes.

21 January 2018

1 reference

Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

21 January 2018

1 reference

Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment

21 January 2018

1 reference

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

21 January 2018

1 reference

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells

21 January 2018

1 reference

Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets

21 January 2018

1 reference

Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia

21 January 2018

1 reference

Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.

21 January 2018

1 reference

Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.

21 January 2018

1 reference

Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.

21 January 2018

1 reference

Impairment of plasmacytoid dendritic cells for IFN production by the ligand for immunoglobulin-like transcript 7 expressed on human cancer cells

21 January 2018

1 reference

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

21 January 2018

1 reference

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand

21 January 2018

1 reference

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.

21 January 2018

1 reference

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

21 January 2018

1 reference

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

21 January 2018

1 reference

Successful treatment of perianal Bowen's disease with imiquimod

21 January 2018

1 reference

Tumoricidal activity of human dendritic cells.

21 January 2018

1 reference

Killer dendritic cells and their potential for cancer immunotherapy.

21 January 2018

1 reference

Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate

21 January 2018

1 reference

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

21 January 2018

1 reference

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity

21 January 2018

1 reference

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells

21 January 2018

1 reference

Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

21 January 2018

1 reference

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

21 January 2018

1 reference

Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry

21 January 2018

1 reference

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination

21 January 2018

1 reference

Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

21 January 2018

1 reference

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

21 January 2018

1 reference

Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas

21 January 2018

1 reference

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12363

1 reference

1 September 2017

1 reference

PubMed ID

25524580